Throughout the country men are filing lawsuits against manufacturers of low testosterone medications after suffering heart attacks, strokes and other cardiovascular issues while taking the treatment.
Low Testosterone Therapy Lawsuits Grow with Filings in Illinois
Many men around the country have filed low testosterone lawsuits against manufacturers who develop treatment options for this condition, which can lead to serious cardiovascular risks including heart attack and stroke.
Low-T Victims and Families File Lawsuits Against Manufacturers
Low testosterone is a common issue among men, especially those who are older, but many therapies to treat this condition can have devastating side effects.
Axiron and Other Low Testosterone Therapy Claims May be Consolidated
Men across the U.S. are filing lawsuits against the manufacturers of low testosterone treatments after suffering heart attacks, strokes and other cardiovascular events.
Progression of Low Testosterone Litigation Continues
Many low testosterone drug manufacturers continue to face lawsuits from men who say the companies failed to provide sufficient warnings of the dangerous and potentially life-threatening side effects of the treatments, which include AndroGel, Fortesta, Axiron, Testim and Striant.
Low Testosterone Plaintiffs Claim Low T Drugs May Cause Heart Attacks
Lawsuits against manufacturers of low testosterone treatments continue to be filed around the U.S. by men who suffered heart attacks and other life-threatening cardiac events allegedly because of these medications.
Investigators Find Dangerous Low Testosterone Medication Side Effects
Throughout the U.S., millions of men are taking low testosterone therapy drugs to improve their libido and muscle mass as well as boost their energy levels, according to Pam Zekman of CBS Chicago.
After Suffering Heart Attacks, Men on Low T Treatment File Lawsuits
After Stephan Nichols, 59, suffered a heart attack while taking the popular low testosterone treatment drug AndroGel, he decided to sue the manufacturers of the medication, according to a Denver CBS News affiliate KCNC.